ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2 |
| |
Authors: | Chiaki Tanabe Nika Hotoda Eugene Futai Shoichi Ishiura |
| |
Affiliation: | a Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan b Department of Neuroscience, School of Pharmacy, Iwate Medical University, 2-1-1 Nishitokuda, Yahaba, Iwate 028-3694, Japan |
| |
Abstract: | ADAM family proteins are type I transmembrane, zinc-dependent metalloproteases. This family has multiple conserved domains, including a signal peptide, a pro-domain, a metalloprotease domain, a disintegrin (DI) domain, a cysteine-rich (Cys) domain, an EGF-like domain, a transmembrane domain, and a cytoplasmic domain. The Cys and DI domains may play active roles in regulating proteolytic activity or substrate specificity. ADAM19 has an autolytic processing activity within its Cys domain, and the processing is necessary for its proteolytic activity. To identify a new physiological function of ADAM19, we screened for associating proteins by using the extracellular domain of ADAM19 in a yeast two-hybrid system. Cysteine-rich protein 2 (CRIP2) showed an association with ADAM19 through its DI and Cys domains. Sequence analysis revealed that CRIP2 is a secretable protein without a classical signal. CRIP2 secretion was increased by overexpression of ADAM19 and decreased by suppression of ADAM19 expression. Moreover, CRIP2 secretion increased in parallel with the autolytic processing of ADAM19 stimulated by lipopolysaccharide. These findings suggest that ADAM19 autolysis is activated by lipopolysaccharide and that ADAM19 promotes the secretion of CRIP2. |
| |
Keywords: | AD, Alzheimer&rsquo s disease Aβ, amyloid β-peptide ADAM, a disintegrin and metalloprotease APP, amyloid precursor protein sAPP α, soluble APP α 3AT, s-aminotriazole CRIP2, cysteine-rich protein-2 IFN, interferon IL, interleukin LPS, lipopolysaccharide NRG, neuregulin NSAID, non-steroidal anti-inflammatory drug TRANCE, TNF-related activation-induced cytokine |
本文献已被 ScienceDirect 等数据库收录! |
|